SEC Form 4 · accession 0001209191-15-007485

BioRestorative Therapies, Inc. · BRTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners

10% Owner

10% Owner

Period of report

Dec 30, 2013

Accepted (ET)

Jan 29, 2015 · 4:56 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001505497

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F3	Aug 13, 2014	P$0	550,000	—	A	2,665,000	I	See footnote
Common Stock^F2,F3	Dec 31, 2014	P$0	450,000	—	A	3,115,000	I	See footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Common Stock Warrants (right to buy)^F4,F3,F5	$0.75	Dec 30, 2013	J	800,000	A	—	Dec 31, 2015	Common Stock	800,000	800,000	I

F1On August 13, 2014, Westbury (Bermuda) Ltd. ("Westbury") agreed to extend the maturity date of certain notes issued by one of the wholly-owned subsidiaries of BioRestorative Therapies, Inc. (the "Issuer") in the aggregate principal amount of $4,000,000 (the "Notes") from July 31, 2014 to December 31, 2014. In consideration of the extension of maturity, the Issuer issued to Westbury 550,000 shares of the Issuer's common stock.
F2On December 31, 2014, Westbury agreed to extend the maturity date of the Notes from December 31, 2014 to June 30, 2015. In consideration of the extension of maturity, the Issuer issued to Westbury 450,000 shares of the Issuer's common stock.
F3These securities are directly owned by Westbury, which is 100% owned by Westbury Trust. Westbury Trust is an indirect beneficial owner of the reported securities.
F4The warrants were acquired in connection with the amendment to the exercise price of other warrants, which resulted in the deemed cancellation and replacement of such other warrants as was previously reported on a Form 4 filed with the SEC on January 2, 2014.
F5The warrants were exercisable immediately upon issuance.